Larimar Therapeutics, Inc.

Rachunek Zysków i Strat


Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna



Przychody TTM (mln): 0
EBIT TTM (mln): -74
index 0 1 2 3 4 5 6 7 8 9 10 11 12 13
Rok finansowy 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Przychód Δ r/r 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Marża brutto -inf% -inf% -inf% 0.0% 0.0% 0.0% 0.0% 0.0% -inf% -inf% -inf% -inf% -inf% 0.0%
EBIT (mln) -13 -14 -14 -36 -74 -58 -53 -61 -23 -43 -50 -37 -42 -91
EBIT Δ r/r 0.0% 4.8% -0.1% 157.9% 107.7% -21.1% -9.0% 15.3% -62.0% 84.4% 17.9% -27.6% 14.3% 117.7%
EBIT (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% nan
Koszty finansowe (mln) 0 0 0 -1 -0 0 1 -0 -2 0 0 -0 0 0
EBITDA (mln) -13 -14 -14 -36 -75 -57 -51 -61 -23 -43 -50 -37 -41 -91
EBITDA(%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% nan
Podatek (mln) 0 0 0 0 -1 1 2 -0 0 -0 -0 -1 0 0
Zysk Netto (mln) -13 -14 -14 -37 -74 -58 -52 -61 -23 -42 -50 -34 -37 -81
Zysk netto Δ r/r 0.0% 5.5% 1.1% 160.7% 103.1% -22.1% -10.1% 18.0% -62.3% 83.0% 18.9% -32.1% 8.1% 118.1%
Zysk netto (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% nan
EPS -6.07 -6.4 -6.54 -0.003 -33.32 -25.44 -22.76 -22.85 -45.57 -3.56 -2.93 -1.33 -0.84 -1.32
EPS (rozwodnione) -6.07 -6.4 -6.54 -0.003 -33.32 -25.44 -22.76 -22.85 -45.57 -3.56 -2.93 -1.33 -0.84 -1.32
Ilośc akcji (mln) 2 2 2 12,189 2 2 2 3 1 12 17 26 44 61
Ważona ilośc akcji (mln) 2 2 2 12,189 2 2 2 3 1 12 17 26 44 61
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD USD